rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxaminerikkunshi-to减弱不良氟伏沙明引起的胃肠道症状.pdfVIP

BioPsychoSocial Medicine BioMed Central Research Open Access Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine Takakazu Oka*, Yoko Tamagawa, Sota Hayashida, Yuko Kaneda, Naoki Kodama and Sadatoshi Tsuji Address: Division of Psychosomatic Medicine, Department of Neurology, University of Occupational and Environmental Health, Iseigaoka 1-1, Yahatanishi-ku, Kitakyushu, 807-8555, Japan Email: Takakazu Oka* - toka@med.uoeh-u.ac.jp; Yoko Tamagawa - y-ii@med.uoeh-u.ac.jp; Sota Hayashida - hsota@med.uoeh-u.ac.jp; Yuko Kaneda - y-kaneda@med.uoeh-u.ac.jp; Naoki Kodama - kodama-n@med.uoeh-u.ac.jp; Sadatoshi Tsuji - tsujisa@med.uoeh-u.ac.jp * Corresponding author Published: 15 November 2007 Received: 10 July 2007 Accepted: 15 November 2007 BioPsychoSocial Medicine 2007, 1:21 doi:10.1186/1751-0759-1-21 This article is available from: /content/1/1/21 © 2007 Oka et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Upper gastrointestinal (GI) symptoms such as nausea and vomiting are common adverse events associated with selective serotonin reuptake inhibitors (SSRIs), and may result in discontinuation of drug therapy in patients with depressive disorder. Rikkunshi-to (formulation TJ- 43), a traditional herbal medicine, has been reported to improve upper GI symptoms a